These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 36999443)

  • 1. Efficacy of Antihypertensive Drugs of Different Classes After Renal Denervation in Spontaneously Hypertensive Rats.
    Hohl M; Lauder L; Sevimli Ö; Tokcan M; Wagmann L; Götzinger F; Schneider C; Hübner U; Lehnert U; Meyer MR; Böhm M; Mahfoud F
    Hypertension; 2023 Jun; 80(6):e90-e100. PubMed ID: 36999443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olmesartan combined with renal denervation reduces blood pressure in association with sympatho-inhibitory and aldosterone-reducing effects in hypertensive mice with chronic kidney disease.
    Nishihara M; Takesue K; Hirooka Y
    Clin Exp Hypertens; 2019; 41(3):211-219. PubMed ID: 29694249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laboratory tests as predictors of the antihypertensive effects of amlodipine, bisoprolol, hydrochlorothiazide and losartan in men: results from the randomized, double-blind, crossover GENRES Study.
    Suonsyrjä T; Hannila-Handelberg T; Paavonen KJ; Miettinen HE; Donner K; Strandberg T; Tikkanen I; Tilvis R; Pentikäinen PJ; Kontula K; Hiltunen TP
    J Hypertens; 2008 Jun; 26(6):1250-6. PubMed ID: 18475165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and Efficacy of Renal Denervation in Patients Taking Antihypertensive Medications.
    Kandzari DE; Townsend RR; Kario K; Mahfoud F; Weber MA; Schmieder RE; Pocock S; Tsioufis K; Konstantinidis D; Choi J; East C; Lauder L; Cohen DL; Kobayashi T; Schmid A; Lee DP; Ma A; Weil J; Agdirlioglu T; Schlaich MP; Shetty S; Devireddy CM; Lea J; Aoki J; Sharp ASP; Anderson R; Fahy M; DeBruin V; Brar S; Böhm M;
    J Am Coll Cardiol; 2023 Nov; 82(19):1809-1823. PubMed ID: 37914510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olmesartan/amlodipine vs olmesartan/hydrochlorothiazide in hypertensive patients with metabolic syndrome: the OLAS study.
    Martinez-Martin FJ; Rodriguez-Rosas H; Peiro-Martinez I; Soriano-Perera P; Pedrianes-Martin P; Comi-Diaz C
    J Hum Hypertens; 2011 Jun; 25(6):346-53. PubMed ID: 21107432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in Plasma Renin Activity After Renal Artery Sympathetic Denervation.
    Mahfoud F; Townsend RR; Kandzari DE; Kario K; Schmieder RE; Tsioufis K; Pocock S; David S; Patel K; Rao A; Walton A; Bloom JE; Weber T; Suppan M; Lauder L; Cohen SA; McKenna P; Fahy M; Böhm M; Weber MA
    J Am Coll Cardiol; 2021 Jun; 77(23):2909-2919. PubMed ID: 33957242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood pressure changes after catheter-based renal denervation are related to reductions in total peripheral resistance.
    Ewen S; Cremers B; Meyer MR; Donazzan L; Kindermann I; Ukena C; Helfer AG; Maurer HH; Laufs U; Grassi G; Böhm M; Mahfoud F
    J Hypertens; 2015 Dec; 33(12):2519-25. PubMed ID: 26485463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transient prehypertensive treatment in spontaneously hypertensive rats: a comparison of losartan and amlodipine regarding long-term blood pressure, cardiac and renal protection.
    Peng F; Lin J; Lin L; Tang H
    Int J Mol Med; 2012 Dec; 30(6):1376-86. PubMed ID: 23064712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STK39 variation predicts the ambulatory blood pressure response to losartan in hypertensive men.
    Donner KM; Hiltunen TP; Hannila-Handelberg T; Suonsyrjä T; Kontula K
    Hypertens Res; 2012 Jan; 35(1):107-14. PubMed ID: 21993215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of olmesartan medoxomil and hydrochlorothiazide compared with benazepril and amlodipine besylate.
    Kereiakes DJ; Neutel JM; Punzi HA; Xu J; Lipka LJ; Dubiel R
    Am J Cardiovasc Drugs; 2007; 7(5):361-72. PubMed ID: 17953475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of antihypertensive drug responses: initial data from a placebo-controlled, randomized, cross-over study with four antihypertensive drugs (The GENRES Study).
    Hiltunen TP; Suonsyrjä T; Hannila-Handelberg T; Paavonen KJ; Miettinen HE; Strandberg T; Tikkanen I; Tilvis R; Pentikäinen PJ; Virolainen J; Kontula K
    Am J Hypertens; 2007 Mar; 20(3):311-8. PubMed ID: 17324745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sympathoinhibitory Effect of Radiofrequency Renal Denervation in Spontaneously Hypertensive Rats With Established Hypertension.
    Gao J; Kerut EK; Smart F; Katsurada A; Seth D; Navar LG; Kapusta DR
    Am J Hypertens; 2016 Dec; 29(12):1394-1401. PubMed ID: 27538721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistant hypertension: Renal denervation or pharmacovigilance? Insights from a renal denervation screening program.
    Ojrzanowski M; Kasprzak JD; Peruga JZ; Kurpesa M; Jankowski Ł; Sahni S; Plewka M
    Adv Clin Exp Med; 2019 Nov; 28(11):1525-1530. PubMed ID: 31693316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal Sympathetic Denervation Protects the Failing Heart Via Inhibition of Neprilysin Activity in the Kidney.
    Polhemus DJ; Trivedi RK; Gao J; Li Z; Scarborough AL; Goodchild TT; Varner KJ; Xia H; Smart FW; Kapusta DR; Lefer DJ
    J Am Coll Cardiol; 2017 Oct; 70(17):2139-2153. PubMed ID: 29050562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression of kidney injury and cardiac remodeling in obese spontaneously hypertensive rats: the role of renal sympathetic innervation.
    Linz D; Hohl M; Schütze J; Mahfoud F; Speer T; Linz B; Hübschle T; Juretschke HP; Dechend R; Geisel J; Rütten H; Böhm M
    Am J Hypertens; 2015 Feb; 28(2):256-65. PubMed ID: 25023205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The blood pressure-lowering effect of renal denervation is inversely related to kidney function.
    Vink EE; Verloop WL; Bost RB; Voskuil M; Spiering W; Vonken EJ; Bots ML; Blankestijn PJ
    J Hypertens; 2014 Oct; 32(10):2045-53; discussion 2053. PubMed ID: 25023158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal denervation inhibits the renin-angiotensin-aldosterone system in spontaneously hypertensive rats.
    Qin F; Li J; Dai YF; Zhong XG; Pan YJ
    Clin Exp Hypertens; 2022 Jan; 44(1):83-92. PubMed ID: 34818958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma renin activity and aldosterone concentrations in hypertensive cats with and without azotemia and in response to treatment with amlodipine besylate.
    Jepson RE; Syme HM; Elliott J
    J Vet Intern Med; 2014; 28(1):144-53. PubMed ID: 24428319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Six-Month Results of Treatment-Blinded Medication Titration for Hypertension Control After Randomization to Endovascular Ultrasound Renal Denervation or a Sham Procedure in the RADIANCE-HTN SOLO Trial.
    Azizi M; Schmieder RE; Mahfoud F; Weber MA; Daemen J; Lobo MD; Sharp ASP; Bloch MJ; Basile J; Wang Y; Saxena M; Lurz P; Rader F; Sayer J; Fisher NDL; Fouassier D; Barman NC; Reeve-Stoffer H; McClure C; Kirtane AJ;
    Circulation; 2019 May; 139(22):2542-2553. PubMed ID: 30880441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Antihypertensive Medication Changes After Renal Denervation Among Different Patient Groups: SPYRAL HTN-ON MED.
    Townsend RR; Ferdinand KC; Kandzari DE; Kario K; Mahfoud F; Weber MA; Schmieder RE; Pocock S; Tsioufis K; David S; Steigerwalt S; Walton A; Hopper I; Bertolet B; Sharif F; Fengler K; Fahy M; Hettrick DA; Brar S; Böhm M
    Hypertension; 2024 May; 81(5):1095-1105. PubMed ID: 38314554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.